Evidence map›Paper›PMID 28584281›Full record

ArticleScientific reports2017

Mass spectrometry imaging identifies palmitoylcarnitine as an immunological mediator during Salmonella Typhimurium infection.

Heather E Hulme, Lynsey M Meikle, Hannah Wessel, Nicole Strittmatter, John Swales, Carolyn Thomson, Anna Nilsson, Robert J B Nibbs, Simon Milling, Per E Andren and 6 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
5.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. bioRxiv : the preprint server for biology · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 2 countries.

Heather E HulmeInstitute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, G12 8QQ, United Kingdom.
Lynsey M MeikleInstitute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, G12 8QQ, United Kingdom.
Hannah WesselInstitute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, G12 8QQ, United Kingdom.
Nicole StrittmatterAstraZeneca, Milton Science Park, Cambridge, CB4 0WG, United Kingdom.
John SwalesAstraZeneca, Milton Science Park, Cambridge, CB4 0WG, United Kingdom.
Carolyn ThomsonInstitute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, G12 8QQ, United Kingdom.
Anna NilssonBiomolecular Imaging and Proteomics, Department of Pharmaceutical Biosciences, Uppsala University, Box 591 BMC, Uppsala, 751 24, Sweden.
Robert J B NibbsInstitute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, G12 8QQ, United Kingdom.
Simon MillingInstitute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, G12 8QQ, United Kingdom.ORCID 0000-0003-4384-5516
Per E AndrenBiomolecular Imaging and Proteomics, Department of Pharmaceutical Biosciences, Uppsala University, Box 591 BMC, Uppsala, 751 24, Sweden.
C Logan MackaySchool of Chemistry, University of Edinburgh, Edinburgh, EH9 3FJ, United Kingdom.
Alex DexterNational Physical Laboratory, Teddington, Middlesex, TW11 0LW, United Kingdom.
Josephine BunchNational Physical Laboratory, Teddington, Middlesex, TW11 0LW, United Kingdom.
Richard J A GoodwinAstraZeneca, Milton Science Park, Cambridge, CB4 0WG, United Kingdom.
Richard BurchmoreInstitute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, G12 8QQ, United Kingdom. richard.burchmore@glasgow.ac.uk.
Daniel M WallInstitute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, G12 8QQ, United Kingdom. donal.wall@glasgow.ac.uk.
University of Glasgow · GBAstraZeneca (United Kingdom) · GBNational Physical Laboratory · GBUppsala University · SEUniversity of Edinburgh · GB

Funding

Biotechnology and Biological Sciences Research Council B/K008005/1Medical Research Council MR/L000598/1Medical Research Council MR/N023625/1
6 · The paper itself

Abstract

Salmonella Typhimurium causes a self-limiting gastroenteritis that may lead to systemic disease. Bacteria invade the small intestine, crossing the intestinal epithelium from where they are transported to the mesenteric lymph nodes (MLNs) within migrating immune cells. MLNs are an important site at which the innate and adaptive immune responses converge but their architecture and function is severely disrupted during S. Typhimurium infection. To further understand host-pathogen interactions at this site, we used mass spectrometry imaging (MSI) to analyse MLN tissue from a murine model of S. Typhimurium infection. A molecule, identified as palmitoylcarnitine (PalC), was of particular interest due to its high abundance at loci of S. Typhimurium infection and MLN disruption. High levels of PalC localised to sites within the MLNs where B and T cells were absent and where the perimeter of CD169

Indexed as

Mass SpectrometryAnimalsBiomarkersFemaleImmunologic FactorsMicePalmitoylcarnitineSalmonella Infections, AnimalSalmonella typhimuriumSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationBiomarkersImmunologic FactorsPalmitoylcarnitine

Identifiers

PMID28584281
PMCPMC5459799
OpenAlexW2618729882

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.